146TiPEXalt3: A phase III study of ensartinib (X-396) in anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC)Leora Horn,Y.-L. Wu,M. Reck,C. Liang,F. Tan,K. Harrow, V. Oertel,G. Dukart,T. MokAnnals of Oncology(2017)引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要